In summary, our study for the first time revealed a novel LINC00342-miR-19a-3p-NPEPL1 regulatory network in the pathogenesis and development of CRC: LINC00342 promoted CRC progression by competitively binding miR-19a-3p with NPEPL1. This evidence concerns the gene NPEPL1 and colorectal carcinoma.